Are we facing an epochal turning point? Indeed, researchers may have discovered the weak point of cancer, even at the terminal stage.
A team of researchers fromUniversity College Londonin fact, he managed to identify a strategy, supported by funding from Cancer Research UK and the Rosetrees Trust. The research, published in Science, explains how the genetic complexity of tumors can be recognized and exploited by the immune system.
In fact, when a cancer develops in the human body, the diversity of its genetic defects can be "marked" on the surface of the cancer cells. You want to try to target only cancer cells, all at once, based on the genetic signature of the disease. The research states that in the future “scientists will be able to exploit this by developing a therapeutic vaccine to activate T cells [of immune cells] or to grow, grow and administer T cells in the patient who has the common antigens in each cancer cell ”.
The head of research, Dr. Sergio Quezada, claimed that one can wipe out a tumor forever by studying the complex genetics of cancer. The very first defects that cancer produces would be found in all the cells that form what is considered the "trunk" of the disease. By studying these defects and fighting them one can theoretically destroy all diseased cells.
Personalized medicine is therefore making giant strides, reaching the point of studying different antibodies for each type of "defect" created by a different tumor.
